Cooper Companies Inc (NYSE:COO)’s share price fell 0.2% on Friday . The stock traded as low as $322.38 and last traded at $323.77. 6,006 shares traded hands during trading, a decline of 98% from the average session volume of 300,573 shares. The stock had previously closed at $324.56.
Several equities analysts have commented on COO shares. Wells Fargo & Co upped their price target on Cooper Companies from $325.00 to $356.00 and gave the company an “outperform” rating in a report on Monday. Zacks Investment Research upgraded shares of Cooper Companies from a “hold” rating to a “buy” rating and set a $336.00 price objective for the company in a research note on Friday, June 7th. Northcoast Research restated a “buy” rating and issued a $340.00 price objective (up previously from $331.00) on shares of Cooper Companies in a research note on Monday, June 3rd. Jefferies Financial Group increased their price target on shares of Cooper Companies to $330.00 and gave the stock a “buy” rating in a research report on Wednesday, March 6th. Finally, Stephens increased their price target on shares of Cooper Companies from $305.00 to $320.00 and gave the stock an “overweight” rating in a research report on Wednesday, March 6th. One research analyst has rated the stock with a sell rating, one has assigned a hold rating and eleven have assigned a buy rating to the stock. Cooper Companies presently has an average rating of “Buy” and an average target price of $315.36.
The firm has a market cap of $16.24 billion, a price-to-earnings ratio of 28.10, a price-to-earnings-growth ratio of 2.49 and a beta of 0.78. The company has a debt-to-equity ratio of 0.42, a current ratio of 1.21 and a quick ratio of 0.68.
In other news, CFO Brian G. Andrews sold 1,648 shares of Cooper Companies stock in a transaction that occurred on Monday, March 25th. The shares were sold at an average price of $293.28, for a total transaction of $483,325.44. Following the completion of the sale, the chief financial officer now owns 1,101 shares in the company, valued at approximately $322,901.28. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director Robert S. Weiss sold 70,902 shares of Cooper Companies stock in a transaction that occurred on Tuesday, March 19th. The stock was sold at an average price of $291.81, for a total transaction of $20,689,912.62. Following the sale, the director now owns 117,185 shares of the company’s stock, valued at approximately $34,195,754.85. The disclosure for this sale can be found here. Insiders sold a total of 150,856 shares of company stock valued at $46,131,542 in the last 90 days. Corporate insiders own 1.70% of the company’s stock.
Several large investors have recently modified their holdings of COO. Executive Wealth Management LLC acquired a new position in shares of Cooper Companies in the 4th quarter valued at approximately $34,000. Financial Gravity Companies Inc. acquired a new position in shares of Cooper Companies during the fourth quarter worth about $46,000. Quadrant Capital Group LLC boosted its position in Cooper Companies by 827.8% during the 1st quarter. Quadrant Capital Group LLC now owns 167 shares of the medical device company’s stock worth $47,000 after acquiring an additional 149 shares during the last quarter. Zions Bancorporation N.A. acquired a new position in Cooper Companies during the 1st quarter worth approximately $53,000. Finally, CNB Bank acquired a new position in Cooper Companies during the 1st quarter worth approximately $59,000. Institutional investors own 95.98% of the company’s stock.
COPYRIGHT VIOLATION NOTICE: “Cooper Companies (NYSE:COO) Stock Price Down 0.2%” was first reported by Markets Daily and is owned by of Markets Daily. If you are accessing this story on another domain, it was illegally stolen and reposted in violation of US and international trademark and copyright laws. The legal version of this story can be read at https://www.themarketsdaily.com/2019/06/14/cooper-companies-nysecoo-stock-price-down-0-2.html.
About Cooper Companies (NYSE:COO)
The Cooper Companies, Inc operates as a medical device company worldwide. It operates through CooperVision and CooperSurgical business units. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia.
Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.